Critical Care Flashcards

1
Q

Sepsis definition

A

life-threatening organ dysfunction caused by a dysregulated host response to infection

Organ dysfunction defined by the SOFA score

New definition eliminates SIRS because of the poor sensitivity and specificity of these criteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SOFA score?

A

range, 0–24 with higher scores indicating more severe illness) ≥2 points from baseline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SOFA score what does it measure?

A

Neuro- GCS- 15 Resp- PaO2/FiO2 >=400 CV- MAP/vasopressors requirement- >=70 Liver- Bilirrubin <1.2 Renal- Creatinine or urine output- Cr <1.2 Coagulation - platelets > 150

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SOFA score

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

quick SOFA

A

Patient in ICU

alteration in mental status

systolic blood pressure ≤100 mm Hg

respiratory rate ≥22/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Septic Shock definition

A

development of shock (circulatory failure that causes inadequate cellular oxygen utilization) from sepsis (as defined above).

Patients with septic shock have persistent hypotension despite volume resuscitation and require vasopressors to maintain a mean arterial pressure >70 mm Hg. Hospital mortality associated with septic shock is ≥40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment Septic Shock

A

1.Early antibiotic therapy:each hour of delay in delivery of appropriate antibiotics increased mortality by about 7%.

Antibiotics should be targeted to the organisms most likely to cause infection in the suspected organ system; if the source of infection is not yet known, empiric broad-spectrum antibiotics are indicated.

2. Volume resuscitation:

Crystalloids, including IV normal saline or lactated Ringer’s solution, are the fluids of choice for resuscitation of severe sepsis and septic shock.

Initial fluid challenge should be at a minimum of 30 cc/kg of crystalloids (~2L for a 70 kg adult) for patients with sepsis-induced hypoperfusion.

3. Vasopressors:

Vasopressors should be initiated if a patient is not responsive to fluid resuscitation.

The safest way to deliver vasopressors is through central venous access (internal jugular, subclavian, femoral catheter, or peripherally inserted central cannula).

Surviving Sepsis Campaign guidelines recommend norepinephrine as the first-choice vasopressor in septic shock.

Other treatments: Many therapies that have been used in the treatment of septic shock are no longer part of clinical practice because high-quality trials have not shown benefit (and have sometimes shown harm). Examples include hydrocortisone (benefit disproven in septic shock in the CORTICUS trial and more recently in severe sepsis in the HYPRESS trial) and activated protein C (initially promising in PROWESS but later disappointing in PROWESS-SHOCK).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Shock definition

A

circulatory failure that causes inadequate cellular oxygen utilization associated with the presence of the following:

  • systemic arterial hypotension
  • clinical signs of tissue hypoperfusion (cool and clammy skin, low urine output, altered mental status)
  • increased serum lactate level
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MAP formula

A

Mean arterial pressure = cardiac output (CO) x systemic vascular resistance (SVR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of Shock

A

Mean arterial pressure = cardiac output (CO) x systemic vascular resistance (SVR); therefore, shock can be due to a decrease in SVR, CO, or both.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examples distributive shock

A

Sepsis, Anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples Hypovolemic shock

A

Hemorrhage, internal fluid lossess( third spacing) and external fluid loss ( GI )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examples obstructive shock

A

Pulmonary embolism, cardiac tamponade, tension pneumothorax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Examples cardiogenic shock

A

Acute MI

Advanced valvular disease

End-stage cardiomyopathy

Myocarditis

Cardiac Arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hypotension

A

Usually SBP < 90 or MAP < 70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tissue Hypoperfusion ( “ 3 windows of the body “)

A
  1. Cutaneus: skin is cold and clammy, with vasoconstriction and cyanosis- findings are most evident at low-flow states
  2. renal ( urine output < 0.5 ml/kg/hr)
  3. Neurologic ( altered mental state, typically includes obtundation, disorientation and confusion )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hyperlactemia values

A

normal lactate is ~ 1mmol per liter

hyperlactemia > 1.5 mmol/lt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What do hypovolemia, cardiogenic and obstructive shock have in common that differentiate them from distributive shock?

A

The first 3 have low cardiac output hence inadequate oxygen transport.

In distributive shock the main deficit lies in perophery, with decreased SVR and altered oxygen extraction. They have high CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Initial approach to the patient in shock

A
  • monitoring of arterial BP
  • Blood sampling
  • Central venous catheter for infusion of fluids and vasoactive agents and to guide fluid therapy
  • MNEMONIC VIP:
    1. Ventilate ( O2 administration)
    2. Infuse ( fluid resuscitation)
    3. Pump ( admistration of vasoactive agents)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Ventilatory support in shock

A

Immediate O2 delivery to prevent pulmonary HTN.

Pulse oximetry is often unreliable as a result of peripheral vasoconstriction - so to evaluate O2 requirements require blood gas monitoring

Endotracheal intubation: all patients with severe dyspnea, hypoxemia, or persistent or worsening acidemia ( ph<7.30)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Advantages of Invasive mechanical ventilation in shock

A

Reduce O2 demand of respiratory muscles

decrease LV afterload by increasing intrathoracic pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Abrupt decrease in arterial pressure after initiation of invascive mechanical ventilation strongly suggests?

A

hypovolemia and a decrease in venous return

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Aim of fluid resuscitation in shock

A

improve microvascular blood flow and increase cardiac output.

  • ideal is that CO becomes preload-independent

Even in patients with cardiogenic shock- since acute edema can result in a decrease in the effective intravascular volume

Close monitoring of fluid to avoid risk of edema and its unwanted consequences.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Fluid-challenge goal

A

Determine a patients actual response to fluids while limiting the risks of Adverse Effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Fluid challenge technique ( 4 elements)

A
  1. Type of fluid- crystalloids first line - well tolerated and cheap
    - Use of albumin to crrect severe hypoalbuminemia in some pts
  2. Rate of fluid administration: 300-500ml of fluid during a period of 20-30 min.
  3. Define objective of fluid challenge: 1. increase in Systemic arterial pressure, decrease HR, or increase urine output
  4. Safety: the major risk is pulmonary edema= so define a limit of CVP to prevent fluid overload.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

First line vasopressors in shock - and why

A

Adrenergic agonists - rapid onset of action , high potency , short half life allows easy dose adjustment

NE usually first line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Why pure apha blockers are not preferred as vasopressors ( ie. phenylephrine)?

A

Because besides increasing vascular tone and blood pressure ( desirable in shock) they decrease cardiac output and impair tissue blood flow ( especially in hepatosplachnic region )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Norepinephrine

A

alpha adrenergic properties and modest b blockers- help maintint CO.

Increases MAP with little change HR or CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Norepinephrine dose

A

0.1-2 mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Dopamine MOA

A

Predominantly B adrenergic effects ( increase HR and contractility) at lower doses and alpha adrenergic effects at higher doses but its effects are relatively weak

NOT A FIRST LINE TTO IN SHOCK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Epinephrine

A

predominantly B adrenergic effects at low doses, with alpha adrenergic at higher doses.

Increased rate of arrythmia and decrease in splachnic blood flow, latate levels

NO benefit of epinephrine over Epinephrine in septic shock

SECOND LINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Vasopressin deficiency in shock?

A

Can develop in patients with very hyperkinetic forms of distributive shock ad the administration of low dose vasopressin may result in substantial increases in arterial pressure.

– should not be given at doses higher than 0.04 U per minute and should be administered only in patients with high level of CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

First line inotrope in shock? when is it used?

A

Dobutamine - to increase CO regardless of whether NE is also being given.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Dobutamine MOA

A

predominantly B adrenergic properties, less likely to induce tachycardia than isoproterenol.

limited effects on arterial pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Milrinone and enoximone MOA

A

PDE III - Combine inotropic and vasodilating properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Advantages of PDE III inhibitors ( Milrinone, enoximone)

A

by Decrease metabolism of cAMP- reinforce effects of dobutamine

Can be useful in patients with b blockers.

38
Q

PDE III inhibitors disadvantages

A

not recommended in patients with hypotension

very long half-lifes ( 4-6 hrs) - preventing the minute to minute adjustment

Prefered to be given in short term infusions of small doses rather than continuous infusions

39
Q

Levosimendan MOA

A

binds to cardiac troponin C and increases calcium sensitivity of myocites.

Acts as vasodilator by opening ATP- sensitive potassium channels in vascular smooth muscle.

40
Q

Levosimendan disadvantage

A

long half life (days) limiting practicality of its use in acute shock states

41
Q

Goals of hemodynamic support

A

Arterial pressure 65-70mmHg is a good initial goal but levels should be adjusted to restore tissue perfusion -assessed by mental status, skin appearance and urine output.

42
Q

Four phases in the treatment of shock

A

Salvage

Optimization

Stabilization

De-escalation

43
Q

Four phases in the treatment of shock

Salvage

A

Obtain a minimal acceptable blood pressure- perform life saving measures

44
Q

Four phases in the treatment of shock

Optimization

A

Provide adequate oxygen availability - optimize CO, SVO2, lactate

45
Q

Four phases in the treatment of shock

Stabilization

A

Provide organ support- minimize complications

46
Q

Four phases in the treatment of shock

De-escalation

A

Wean from vasoactive agents- achieve a negative fluid balance.

47
Q

In low-flow states mechanism of hyperlactatemia vs. distibutive shock

A

In low-flow states- tissue hypoxia with development of anaerobic metabolism

Distributive shock- may also involve increased glycolysis and inhibition of pyruvate dehydrogenase

In both cases -altered clearance can be fue to impaired liver function

48
Q

Hyperlactatemia

A

In patients with shock and a
blood lactate level of more than 3 mmol per liter,
Jansen et al.24 found that targeting a decrease
of at least 20% in the blood lactate level over a
2-hour period seemed to be associated with reduced
in-hospital mortality.

49
Q

TTO of anaphylactic shock (a form of distributive shock):

A

IV epinephrine

50
Q

Tto of hemorrhagic shock

A

blood transfusions

51
Q

Tto pulmonary embolism

A

systemic thrombolytics

52
Q

Tto cardiogenic shock:

A

inotropes and sometimes mechanical support (e.g., intra-aortic balloon pump)

53
Q

Principles of vasopressors in shock

A

Patients with distributive, hypovolemic, and obstructive shock should be given IV fluid resuscitation prior to initiation of vasopressors.

Typically, vasopressors are titrated to a mean arterial pressure of 65 mm Hg, although decreasing lactate level and improving urine output are reassuring signs of adequate organ perfusion.

Inotropes may be indicated in the treatment of cardiogenic shock from primary pump failure.

54
Q

Vasopressors

A
55
Q

NE mechanism of action, indications

A

a1 >>b1> b2

Indicated in shock ( distributive, cardiogenic, mixed)

FIRST LINE VASOPRESSOR IN SHOCK

56
Q

NE side effects

A

arrhythmias, peripheral ( digital) ischemia

57
Q

NE effect on SVR and CO

A

Increases both

58
Q

Phenylephrine (Neosynephrine) MOA and indications

A

a1

increases SVR

distributive shock

useful in tachyarrhythmias

59
Q

Phenylephrine EA

A

reflex tachycardia and severe peripheral and visceral vasoconstriction

60
Q

Vasopressin MOA and indications in shock

A

V1,V2

Increases SVR

Add to NE in septic shock

61
Q

Vasopressin SE

A

arrhythmias, cardiac ischemia, peripheral and splachnic vasoconstriction

62
Q

Epinephrine MOA, indications

A

a1>b1> b2

increases HR, SVR, CO

Indications: shock ( anaphylactic, cardiogenic, distributive) cardiac arrest and bronchospasm

FIRST LINE TTO FOR ANAPHYLAXIS AND CARDIAC ARREST

63
Q

Epinephrine EA

A

Ventricular arrhythmias, cardiac ischemia

64
Q

Dopamine MOA and clinical indications

A

D1 >> B1>A1>B2

Immediate precursor of NE

increases CO, mild increase SVR

iNDICATIONS: Bradycardia, shock ( cardiogenic, distributive)

65
Q

Dopamine SE

A

ventricular arrhythmia, cardiac ischemia, tissue ischemia or gangrene

66
Q

Dobutamine MOA and clinical indication

A

B1>>B2>A1

Increases HR

USED IN CARDIOGENIC SHOCK

IS AN INOTROPE, CAN CAUSE HYPOTENSION

67
Q

B1 adrenergic receptor stimulation

A

myocardial contraction through Ca2+ mediated facilitation of actin-myosin complex binding with troponin C and enhance chronicity through Ca2+ channel activation.

68
Q

B2 adrenergic receptor stimulator

A

Vasodiation - increased Ca2+ uptake by the Sarcoplasmic reticulum

69
Q

a1 adrenergic receptors stimulation

A

smooth muscle contraction and increase in SVR

70
Q

Stimulation of D1 and D2 dopaminergic receptors in kidney and splachnic vasculature-

A

renal and mesenteric vasodilation

71
Q

Monroe Kellie Doctrine

A

cranial compartment is not compressible. When the volume increases too much, usually at volumes greater than 100-120mL the intracranial pressure begins to rise

72
Q

Equation of Cerebral Perfusion pressure and targets in ICP

A

CPP =MAP- ICP

When ICP increases cerebral perfusion will decrease

<4 years 50

4-10 years. 60

>9 years 70

73
Q

CSF functions

A
  1. Absorb shock to CNS
  2. Cushions CNS from bony surroundings
  3. Helps circulate nutrients and waste
74
Q

Normal ICP value

A

5-15 mmHg ( or 7-20 cm of H2O)

75
Q

Differential diagnosis in ICP

A
  • Space occupying lesions
  • Diffuse cerebral edema
  • Hydrocephalus
  • Miscellaneous
76
Q

Causes of space occupying lesions that can cause increased ICP

A

Intracranial bleeding: intraparenchymal, subdural,epidural

Tumor

Abscess

77
Q

Causes of diffuse cerebral edema that can cause increased ICP

A

Head trauma

diffuse axonal injury

Meningitis/Encephalitis

Hepatic encephalopathy

Reye’s Sx

Electrolyte shift

Dialysis

DKA

HTN encephalopathy

Post-anoxic brain injury

lead

uncompensated hypercapnia

78
Q

Causes of hydrocephalus that can cause increased ICP

A

head trauma

cerebella hemorrhage/infarct

subarachnoid hemorrhage

mening/encephalitis (specially basilar)

aqueductal stenosis

hindbrain malformations

leptomeningeal metastasis

obstructing mass lesions

79
Q

Miscellaneous Causes of increased ICP

A

craniosynostosis

venous sinus thrombosis

pseudotumor cerebri

cryoglobulinemia

iron def anemia

SLE

80
Q

Drugs that Cause of increased ICP

A

nitrofurantoin

phenytoin

sulfonamides

tetracyclines

vit A

steroids

OCP

81
Q

Types of cerebral edema and how they differ

A

Vasogenic, cytotoxic, hydrocephalus/intersticial

1.Vasogenic: increased permeability, location is the white matter, edema fluid is plasma infiltrate, the extracellular fluid volume is increased

Associated with tumor, abscess, infarction, lead, meningitis

2.Cytotoxic: cellular swelling, location grat and white matter, edema fluid is intracellular H20 and Na, the extracellular fluid is decreased

Associated with : decreased osmolality, ischemia,meningitis, Reye’s syndrome

  1. Hydrocephalus/interstitial: increased intraventricular fluid, location is periventricular matter, edema fluid is CSF, extracellular fluid increased.

Communicating vs. non communicating

82
Q

Cushings triad

A

Hypertension,bradycardia, irregular respirations

83
Q

Intracranial hypotension causes

A
  1. LP/ EVD (external ventricular drain)
  2. CSF leak following trauma, neurosurgery, thoracotomy (CSF.-pleural fistula)
  3. Dural tear
84
Q

Intracranial hypotension presentation

A

intracranial hypotensioncauses stretch of dura and cortical veins ( pain sensitive structures)–> headache, compensatory vasodilation, and TACHYCARDIA ( Different from cushings)

85
Q

Types of intracranial monitoring and purpose

A

Types: epidural, intraparenchymal, subarachnoid, ventricular, subdural

Goal: early detection of decompensation

  1. Preserve cerebral perfussion

Prevent herniation

Devices: Piezoelectric strain gauge

Fiberoptic monitoring

Pneumatic monitori

86
Q

Indications for ICP monitoring

A

GCS 3-8

Clinical signs ( posturing, cushings triad)

Imaging consistent ( small cysterns)

Obscured neuroexamand at risk

Increased risk of ICP

87
Q

Where do you insert the ICP monitoring

A

non dominant hemisphere - R

11 cm and 3 cm

Depth 15 mm into the cranium

88
Q

Contraindications for ICP monitoring

A

Coagulopathy

Plt< 100,000

Plt dysfunction (aspirin)

INR> 1.3

local infection at site

89
Q

Herniation syndromes

A
  1. Subfalcine: aka midline shift or cingulate hernia, mass effect with medial direction of the ipsilateral cingulate gyrus beneath the free edge of the falx cerebri
  2. Central herniation: Downward displacement of the brainstem , mild traction VI nerve ,if severe medullary injury and even respiratory depression
  3. Transtentorial, uncal:medial temporal lobe herniates inferiorly through the tentorial notch. Triad blow pupil, hemiplegia, coma
  4. Tonsillar herniation
90
Q

Goals in ICP

A
  1. ICP < 15-20 ( lower <10-15 if skull fx/defect, higher <20-30 ifmetabolic defects)
  2. CPP > 50-70
  3. CI > 2.5-3 ( may consider pressors)

euvolemia to hypervolemia

normotension

91
Q

ICP management

A
  1. Elevate head 30 degrees and midline, neck position neutral and noncompressed. ( enhance cerebral venous OUTFLOW)
  2. Temporal hyperventilation:Pco2 35-40 ideally
  3. CSF drainage: removal of CSF ideally through ventriculostomy
  4. Mannitol: 0.5-2 g/kg up to 300 osm
  5. Hypertonic Saline: 5-10 mL/kg 3% NaCL up to 145-180 meq/L. May bolus 5-10 ml/kg. and start a gtt @ 0.5-2ml/kg/hr
  6. Craniectomy